Literature DB >> 16702895

To what extent do the PANSS and CGI-S overlap?

Jonathan Rabinowitz1, Angelika Mehnert, Marielle Eerdekens.   

Abstract

BACKGROUND: The Positive and Negative Symptom Scale (PANSS) and Clinical Global Impression (CGI-S) item for severity are used together to measure severity of psychotic illness. PANSS is the "gold standard" measure of efficacy, but it is not always feasible to use, yet the CGI-S requires validation.
OBJECTIVES: To examine the overlap between PANSS and CGI-S.
METHODS: The overlap of the PANSS and CGI-S were examined using data from 7 large antipsychotic clinical trials (n = 4287).
RESULTS: Regression analysis identified 21% to 60% overlap of the measures depending on the trial and measurement point. The pooled study mean PANSS value corresponding with a CGI-S of 2, 3, and 4 were 67.1 (n = 799), 79.6 (n = 1645), and 92.4 (n = 1056), respectively. A decrease of 1 on the CGI-S corresponded to a 20% decline on the PANSS. Of the 37 planned comparisons in these studies, there was an agreement between the PANSS and CGI-S on change from baseline to end point on 32 comparisons and on dichotomized change variables (PANSS > or =-20% and CGI-S > or =-1 point) on 31 comparisons. The differences in the remaining comparisons would not have changed the conclusions of the studies. The positive and disorganized PANSS scales were the most closely related to the CGI-S, followed by hostility and negative scale with almost no association with anxiety/depression.
CONCLUSIONS: The CGI-S and PANSS are correlated but are not synonymous. Both measures, however, show substantial agreement in detecting change, and the CGI-S shows overlap with the core symptoms of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702895     DOI: 10.1097/01.jcp.0000218407.10362.6e

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  11 in total

1.  Quality of Life in Patients with Chronic Psychotic Disorders: A Practical Model for Interventions in Romanian Mental Health Centers.

Authors:  Marinela Hurmuz; Mirela Frandes; Anca-Livia Panfil; Ileana-Pepita Stoica; Cristina Bredicean; Catalina Giurgi-Oncu; Ion Papava; Aurel Nirestean
Journal:  Medicina (Kaunas)       Date:  2022-04-28       Impact factor: 2.948

2.  Modelling and forecasting Positive and Negative Syndrome Scale scores to achieve remission using time series analysis.

Authors:  Alka Sabharwal; Gurprit Grover; Sakshi Kaushik; K E Sadanandan Unni
Journal:  Int J Methods Psychiatr Res       Date:  2019-01-16       Impact factor: 4.035

3.  Noninferiority of perphenazine vs. three second-generation antipsychotics in chronic schizophrenia.

Authors:  Robert Rosenheck; Haiqun Lin
Journal:  J Nerv Ment Dis       Date:  2014-01       Impact factor: 2.254

4.  Minimum clinically important difference in the Positive and Negative Syndrome Scale with data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).

Authors:  Eric D A Hermes; Daniel Sokoloff; T Scott Stroup; Robert A Rosenheck
Journal:  J Clin Psychiatry       Date:  2012-04       Impact factor: 4.384

Review 5.  Selective noradrenaline reuptake inhibitors for schizophrenia.

Authors:  Paul R L Matthews; Jamie Horder; Michael Pearce
Journal:  Cochrane Database Syst Rev       Date:  2018-01-25

6.  Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study.

Authors:  Alex J Mitchell; Davy Vancampfort; Peter Manu; Christoph U Correll; Martien Wampers; Ruud van Winkel; Weiping Yu; Marc De Hert
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

7.  Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment.

Authors:  Parvin Kumar; Paschalis Efstathopoulos; Vincent Millischer; Eric Olsson; Ya Bin Wei; Oliver Brüstle; Martin Schalling; J Carlos Villaescusa; Urban Ösby; Catharina Lavebratt
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

8.  Adaptation of the Clinical Global Impression for Use in Correctional Settings: The CGI-C.

Authors:  Roland M Jones; Kiran Patel; Mario Moscovici; Robert McMaster; Graham Glancy; Alexander I F Simpson
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

9.  Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study.

Authors:  Chi-Un Pae; Changsu Han; Won-Myong Bahk; Soo-Jung Lee; Ashwin A Patkar; Prakash S Masand
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-02-29       Impact factor: 2.582

10.  Validation of the Clinical Global Impression-Corrections Scale (CGI-C) by Equipercentile Linking to the BPRS-E.

Authors:  Roland M Jones; Cory Gerritsen; Margaret Maheandiran; Alexander I F Simpson
Journal:  Front Psychiatry       Date:  2020-03-20       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.